IRIS Accounts Production v26.2.0.496 SC248051 Board of Directors 1.10.24 30.9.25 30.9.25 Medium entities The principal activity of the company is the provision of care and education for young people. 226 217 true false true true false false true false Auditors Opinion These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC2480512024-09-30SC2480512025-09-30SC2480512024-10-012025-09-30SC2480512023-09-30SC2480512023-10-012024-09-30SC2480512024-09-30SC248051ns15:Scotland2024-10-012025-09-30SC248051ns14:PoundSterling2024-10-012025-09-30SC248051ns10:Director12024-10-012025-09-30SC248051ns10:PrivateLimitedCompanyLtd2024-10-012025-09-30SC248051ns10:MediumEntities2024-10-012025-09-30SC248051ns10:Audited2024-10-012025-09-30SC248051ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-10-012025-09-30SC248051ns10:Medium-sizedCompaniesRegimeForAccounts2024-10-012025-09-30SC248051ns10:FullAccounts2024-10-012025-09-30SC248051ns10:OrdinaryShareClass12024-10-012025-09-30SC248051ns10:Director22024-10-012025-09-30SC248051ns10:RegisteredOffice2024-10-012025-09-30SC248051ns5:CurrentFinancialInstruments2025-09-30SC248051ns5:CurrentFinancialInstruments2024-09-30SC248051ns5:Non-currentFinancialInstruments2025-09-30SC248051ns5:Non-currentFinancialInstruments2024-09-30SC248051ns5:ShareCapital2025-09-30SC248051ns5:ShareCapital2024-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2025-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2024-09-30SC248051ns5:ShareCapital2023-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2023-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2024-10-012025-09-30SC24805112024-10-012025-09-30SC248051ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-10-012025-09-30SC248051ns5:PlantMachinery2024-10-012025-09-30SC248051ns5:MotorVehicles2024-10-012025-09-30SC248051ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-10-012025-09-30SC248051ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-10-012024-09-30SC248051ns5:OwnedAssets2024-10-012025-09-30SC248051ns5:OwnedAssets2023-10-012024-09-30SC248051ns5:LeasedAssets2024-10-012025-09-30SC248051ns5:LeasedAssets2023-10-012024-09-30SC248051ns5:HirePurchaseContracts2024-10-012025-09-30SC248051ns5:HirePurchaseContracts2023-10-012024-09-30SC248051ns5:LandBuildings2024-09-30SC248051ns5:PlantMachinery2024-09-30SC248051ns5:MotorVehicles2024-09-30SC248051ns5:LandBuildings2024-10-012025-09-30SC248051ns5:LandBuildings2025-09-30SC248051ns5:PlantMachinery2025-09-30SC248051ns5:MotorVehicles2025-09-30SC248051ns5:LandBuildings2024-09-30SC248051ns5:PlantMachinery2024-09-30SC248051ns5:MotorVehicles2024-09-30SC248051ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-09-30SC248051ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-10-012025-09-30SC248051ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-09-30SC248051ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstruments2025-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30SC248051ns5:WithinOneYearns5:HirePurchaseContracts2025-09-30SC248051ns5:WithinOneYearns5:HirePurchaseContracts2024-09-30SC248051ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-09-30SC248051ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-09-30SC248051ns5:HirePurchaseContracts2025-09-30SC248051ns5:HirePurchaseContracts2024-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-09-30SC248051ns5:WithinOneYear2025-09-30SC248051ns5:WithinOneYear2024-09-30SC248051ns5:BetweenOneFiveYears2025-09-30SC248051ns5:BetweenOneFiveYears2024-09-30SC248051ns5:AllPeriods2025-09-30SC248051ns5:AllPeriods2024-09-30SC248051ns10:OrdinaryShareClass12025-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2024-09-30SC2480512ns10:Director22024-09-30SC2480512ns10:Director22023-09-30SC2480512ns10:Director22024-10-012025-09-30SC2480512ns10:Director22023-10-012024-09-30SC2480512ns10:Director22025-09-30SC2480512ns10:Director22024-09-30
REGISTERED NUMBER: SC248051 (Scotland)













STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2025

FOR

CURO SALUS LIMITED

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025










Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4

Income Statement 7

Other Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 13


CURO SALUS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2025







DIRECTORS: Mrs J Boucetta
Ms K Hampson



REGISTERED OFFICE: Wardhouse Farm
Forehouse Road
Kilbarchan
RENFREWSHIRE
PA10 2PU



REGISTERED NUMBER: SC248051 (Scotland)



SENIOR STATUTORY AUDITOR: Douglas Paton BSc CA



AUDITORS: Bannerman Johnstone Maclay Limited
Chartered Accountants
and Statutory Auditor
213 St Vincent Street
Glasgow
G2 5QY

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2025


The directors present their strategic report for the year ended 30 September 2025.

The principal activity of the company is the provision of care and education for young people.

REVIEW OF BUSINESS
The directors are pleased with the financial performance of the business during the year. Continued investment in staff recruitment, development and training remained a key priority, helping the company respond to ongoing workforce challenges across the sector while maintaining the high standards of care and education expected by those it supports.

The organisation continues to operate within a highly regulated environment, subject to oversight by the Care Inspectorate and Education Scotland. The company's continued focus on safeguarding, quality of care and positive educational outcomes is reflected in the consistently high standards demonstrated across its services. It remains committed to providing vulnerable children with a safe, supportive, and nurturing environment in which they can develop, learn, and thrive.

PRINCIPAL RISKS AND UNCERTAINTIES
During the forthcoming year the board consider the principal risks and uncertainties affecting the company to be:

- Regulatory Compliance
- Workforce Challenges
- Government Policy
- Local Authority Funding

Having considered the risks to the organisation, the board are of the opinion that the company has taken positive action and responded to mitigate the impact of these risks and uncertainties.

KEY PERFORMANCE INDICATORS
The directors and senior management regularly monitor the company's performance by reference to its financial results, including turnover, operating profitability, and cash resources. Performance against budget and the prior year is reviewed throughout the year, with appropriate action taken where significant variations arise. The financial performance and position of the company for the year are reflected in the results and balance sheet set out in these financial statements.

In addition, management monitors operational measures including occupancy levels, staff recruitment and retention, and educational outcomes. These measures assist the directors in assessing service delivery and identifying areas for continuing improvement.

Given the straightforward nature of the company's activities, the directors consider that a more detailed numerical analysis of individual key performance indicators, beyond the information presented elsewhere in these financial statements, is not necessary to provide an understanding of the development, performance, or position of the business.

ON BEHALF OF THE BOARD:





Ms K Hampson - Director


5 August 2026

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2025


The directors present their report with the financial statements of the company for the year ended 30 September 2025.

DIVIDENDS
No dividends will be distributed for the year ended 30 September 2025.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2024 to the date of this report.

Mrs J Boucetta
Ms K Hampson

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Bannerman Johnstone Maclay Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Ms K Hampson - Director


5 August 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Qualified opinion
We have audited the financial statements of Curo Salus Limited (the 'company') for the year ended 30 September 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion, except for the possible effects of the matters described in the Basis for Qualified Opinion section the accompanying financial statements give a true and fair view of the financial position of the Company as at 30 September 2025, and of its financial performance and its cash flows for the year then ended in accordance with Financial Reporting Standard 102.

Basis for qualified opinion
The financial statements do not include certain disclosures in respect of directors' remuneration that are required by Section 412 of the Companies Act 2006. In our judgement,this constitutes a departure from the disclosure requirements of the Act.

The financial statements do not include certain disclosures in respect of related party transactions that are required by Section 33 of FRS 102. In our judgement, the omission of this information constitutes a departure from the requirements of FRS 102.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

As referred to in the Basis for Qualified Opinion, there has been an omission of information regarding directors' remuneration required by the Companies Act 2026.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- We obtained an understanding of the legal and regulatory frameworks applicable to the company and the sector
in which it operates. We determined that the following laws and regulations were the most significant: the
Companies Act 2006 and UK corporate taxation laws.
- We obtained an understanding of how the company is complying with those legal and regulatory frameworks by
making enquires to the management.
- We assessed the susceptibility of the company's financial statements to material misstatement, including how
fraud might occur. Audit procedures performed by the engagement team included:

- identifying and assessing the design and effectiveness of controls management has in place to prevent and
detect fraud;

- understanding how those charged with governance considered and addressed the potential for override of
controls or other inappropriate influence over the financial reporting process;
- challenging assumptions and judgements made by management in its significant accounting estimates;

- identifying and testing journal entries, in particular any journal entries posted with unusual accounting
combinations; and
- assessing the extent of compliance with relevant laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Douglas Paton BSc CA (Senior Statutory Auditor)
for and on behalf of Bannerman Johnstone Maclay Limited
Chartered Accountants
and Statutory Auditor
213 St Vincent Street
Glasgow
G2 5QY

5 August 2026

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2025 2024
Notes £    £   

TURNOVER 13,003,451 12,816,733

Cost of sales 10,842,809 10,018,157
GROSS PROFIT 2,160,642 2,798,576

Administrative expenses 1,770,909 1,755,499
389,733 1,043,077

Other operating income 10,722 -
OPERATING PROFIT 4 400,455 1,043,077

Interest receivable and similar income - 579
400,455 1,043,656
Gain/loss on revaluation of tangible assets - (2,745,592 )
400,455 (1,701,936 )

Interest payable and similar expenses 5 6,494 24,631
PROFIT/(LOSS) BEFORE TAXATION 393,961 (1,726,567 )

Tax on profit/(loss) 6 140,532 210,730
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

253,429

(1,937,297

)

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2025 2024
Notes £    £   

PROFIT/(LOSS) FOR THE YEAR 253,429 (1,937,297 )


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

253,429

(1,937,297

)

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

BALANCE SHEET
30 SEPTEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 3,525,976 3,665,277

CURRENT ASSETS
Debtors 8 1,510,501 1,166,950
Cash at bank 710,528 1,370,988
2,221,029 2,537,938
CREDITORS
Amounts falling due within one year 9 1,694,675 2,375,159
NET CURRENT ASSETS 526,354 162,779
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,052,330

3,828,056

CREDITORS
Amounts falling due after more than one
year

10

26,126

55,281
NET ASSETS 4,026,204 3,772,775

CAPITAL AND RESERVES
Called up share capital 13 2 2
Retained earnings 14 4,026,202 3,772,773
SHAREHOLDERS' FUNDS 4,026,204 3,772,775

The financial statements were approved by the Board of Directors and authorised for issue on 5 August 2026 and were signed on its behalf by:





Ms K Hampson - Director


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2023 2 5,710,070 5,710,072

Changes in equity
Total comprehensive income - (1,937,297 ) (1,937,297 )
Balance at 30 September 2024 2 3,772,773 3,772,775

Changes in equity
Total comprehensive income - 253,429 253,429
Balance at 30 September 2025 2 4,026,202 4,026,204

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 (185,403 ) 1,126,158
Interest paid (854 ) (16,124 )
Interest element of hire purchase payments
paid

(5,640

)

(8,507

)
Tax paid (255,515 ) (263,316 )
Net cash from operating activities (447,412 ) 838,211

Cash flows from investing activities
Purchase of tangible fixed assets (49,335 ) (58,458 )
Interest received - 579
Net cash from investing activities (49,335 ) (57,879 )

Cash flows from financing activities
Loan repayments in year (71,706 ) (273,932 )
Capital repayments in year (52,958 ) (68,635 )
Amount withdrawn by directors (39,049 ) -
Net cash from financing activities (163,713 ) (342,567 )

(Decrease)/increase in cash and cash equivalents (660,460 ) 437,765
Cash and cash equivalents at beginning of
year

2

1,370,988

933,223

Cash and cash equivalents at end of year 2 710,528 1,370,988

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2025


1. RECONCILIATION OF PROFIT/(LOSS) BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2025 2024
£    £   
Profit/(loss) before taxation 393,961 (1,726,567 )
Depreciation charges 188,636 142,615
Loss on revaluation of fixed assets - 2,745,592
Finance costs 6,494 24,631
Finance income - (579 )
589,091 1,185,692
(Increase)/decrease in trade and other debtors (299,855 ) 129,051
Decrease in trade and other creditors (474,639 ) (188,585 )
Cash generated from operations (185,403 ) 1,126,158

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 September 2025
30.9.25 1.10.24
£    £   
Cash and cash equivalents 710,528 1,370,988
Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 1,370,988 933,223


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.10.24 Cash flow At 30.9.25
£    £    £   
Net cash
Cash at bank 1,370,988 (660,460 ) 710,528
1,370,988 (660,460 ) 710,528
Debt
Finance leases (108,239 ) 52,958 (55,281 )
Debts falling due within 1 year (71,706 ) 71,706 -
(179,945 ) 124,664 (55,281 )
Total 1,191,043 (535,796 ) 655,247

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025


1. STATUTORY INFORMATION

Curo Salus Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported during the year for revenue and costs. However the nature of estimation means that actual outcomes could differ from those estimates. Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Useful economic lives of tangible assets
The annual depreciation charge for tangible assets is sensitive to changes in the useful economic lives and residual values of the assets. Useful lives and residual values are reassessed annually. They are assessed where necessary to reflect current estimates based on economic utilisation and physical condition.

Impairment of trade and other debtors
The Company regularly reviews the recoverability of trade and other debtors. A provision for impairment is made where the Company believes that it will not be able to collect amounts due according to the original terms of trade. Provisions for impairment are estimates of future events and are therefore uncertain.

Turnover
Turnover represents the total invoiced value of sales generated during the financial year from the Company’s core activity of providing residential childcare services. Revenue is recognised upon the satisfaction of
performance obligations under contractual agreements, reflecting the entitlement to consideration earned. Income relating to childcare services invoiced either in advance or arrears is deferred or accrued as appropriate, with recognition occurring from the commencement of each placement as services are delivered.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 2% on cost
Plant and machinery - 33% on cost and 10% on cost
Motor vehicles - 25% on cost

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include certain debtors and cash and bank balances, are initially measured at transaction price including transactions costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including certain creditors and loans from related undertakings, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pensions
The company operates a money purchase grouped personal pension scheme for care staff.

The company participates in the Scottish Teachers Pension Scheme. It is a multi-employer defined benefit scheme. It is not possible for the body to identify its share of the underlying assets and liabilities of the scheme on a consistent and reasonable basis. Therefore, the company accounts for the scheme as if it were a defined contribution scheme, as permitted by FRS 102 section 28. As a result, employer contributions are charged to the Statement of Comprehensive Income/Expenditure as they fall due.

3. EMPLOYEES AND DIRECTORS

2025 2024
£ £
Wages and salaries 8,702,456 8,246,165
Social security costs 1,028,567 871,829
Other pension costs 372,014 341,473
10,103,037 9,459,467

The average number of employees during the year was as follows:


2025 2024

Employees 224 215
Directors 2 2
226 217


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


4. OPERATING PROFIT/(LOSS)

The operating profit (2024 - operating loss) is stated after charging:

2025 2024
£    £   
Hire of plant and machinery 72,369 72,629
Depreciation - owned assets 126,515 79,319
Depreciation - assets on hire purchase contracts 62,121 63,296
Auditors' remuneration 16,200 16,200

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank interest 854 16,124
Hire purchase 5,640 8,507
6,494 24,631

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 148,449 255,515

Deferred tax (7,917 ) (44,785 )
Tax on profit/(loss) 140,532 210,730

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit/(loss) before tax 393,961 (1,726,567 )
Profit/(loss) multiplied by the standard rate of corporation tax in the UK of
25% (2024 - 25%)

98,490

(431,642

)

Effects of:
Expenses not deductible for tax purposes 12,292 689,168
Capital allowances in excess of depreciation - (2,011 )
Depreciation in excess of capital allowances 37,667 -
Deferred tax (7,917 ) (44,785 )
Total tax charge 140,532 210,730

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


7. TANGIBLE FIXED ASSETS
Freehold Plant and Motor
property machinery vehicles Totals
£    £    £    £   
COST OR VALUATION
At 1 October 2024 3,450,000 1,076,875 1,026,582 5,553,457
Additions - 40,000 9,335 49,335
At 30 September 2025 3,450,000 1,116,875 1,035,917 5,602,792
DEPRECIATION
At 1 October 2024 - 1,052,225 835,955 1,888,180
Charge for year 69,000 21,165 98,471 188,636
At 30 September 2025 69,000 1,073,390 934,426 2,076,816
NET BOOK VALUE
At 30 September 2025 3,381,000 43,485 101,491 3,525,976
At 30 September 2024 3,450,000 24,650 190,627 3,665,277

All properties were valued in 2024 by Shepherd Commercial, Chartered Surveyors. The valuations were prepared in line with the RICS Red Book guidance and in accordance with the RICS Global Standards incorporating the IVSC International Valuation Standards . This valuation has been incorporated in the accounts.

Cost or valuation at 30 September 2025 is represented by:

Freehold Plant and Motor
property machinery vehicles Totals
£    £    £    £   
Valuation in 2024 (2,745,592 ) - - (2,745,592 )
Cost 6,195,592 1,116,875 1,035,917 8,348,384
3,450,000 1,116,875 1,035,917 5,602,792

If land and buildings had not been revalued they would have been included at the following historical cost:

2025 2024
£    £   
Cost 6,195,592 6,195,592

All properties were valued on an open market basis on 13 August 2023 by J & E Shepherd Surveyors .

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


7. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 October 2024
and 30 September 2025 291,428
DEPRECIATION
At 1 October 2024 180,010
Charge for year 62,121
At 30 September 2025 242,131
NET BOOK VALUE
At 30 September 2025 49,297
At 30 September 2024 111,418

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,250,948 1,122,165
Directors' loan accounts 35,779 -
Deferred tax asset 52,702 44,785
Prepayments and accrued income 171,072 -
1,510,501 1,166,950

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 11) - 71,706
Hire purchase contracts (see note 12) 29,155 52,958
Trade creditors 49,685 58,304
Tax 148,491 255,557
Social security and other taxes 230,229 243,980
Other creditors 33,314 29,786
Directors' loan accounts - 3,270
Accruals and deferred income 1,203,801 1,659,598
1,694,675 2,375,159

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Hire purchase contracts (see note 12) 26,126 55,281

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


11. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank loans - 71,706

12. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2025 2024
£    £   
Gross obligations repayable:
Within one year 32,115 58,599
Between one and five years 28,298 60,413
60,413 119,012

Finance charges repayable:
Within one year 2,960 5,641
Between one and five years 2,172 5,132
5,132 10,773

Net obligations repayable:
Within one year 29,155 52,958
Between one and five years 26,126 55,281
55,281 108,239

Non-cancellable
operating leases
2025 2024
£    £   
Within one year 137,845 80,727
Between one and five years 342,055 311,566
479,900 392,293

13. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
2 Ordinary £1 2 2

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025


14. RESERVES
Retained
earnings
£   

At 1 October 2024 3,772,773
Profit for the year 253,429
At 30 September 2025 4,026,202

15. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2025 and 30 September 2024:

2025 2024
£    £   
Mrs J Boucetta
Balance outstanding at start of year (3,270 ) -
Amounts advanced 39,049 -
Amounts repaid - (3,270 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 35,779 (3,270 )